Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 967 | 1,672 | $517,419 | $108,887 |
| 2022 | 6 | 1,115 | 1,880 | $579,451 | $131,012 |
| 2021 | 6 | 1,218 | 2,025 | $626,774 | $159,082 |
| 2020 | 6 | 1,632 | 2,735 | $848,420 | $219,331 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 163 | 170 | $248,880 | $57,644 | 23.2% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 159 | 660 | $106,260 | $28,469 | 26.8% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 163 | 339 | $123,735 | $14,617 | 11.8% |
| 93017 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) | Office | 2023 | 160 | 167 | $19,873 | $3,500 | 17.6% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 162 | 169 | $11,323 | $2,816 | 24.9% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 160 | 167 | $7,348 | $1,840 | 25.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 187 | 190 | $278,160 | $66,971 | 24.1% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2022 | 183 | 744 | $119,784 | $36,127 | 30.2% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2022 | 186 | 378 | $137,970 | $18,555 | 13.4% |
| 93017 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) | Office | 2022 | 186 | 189 | $22,491 | $3,902 | 17.3% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2022 | 187 | 190 | $12,730 | $3,280 | 25.8% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2022 | 186 | 189 | $8,316 | $2,177 | 26.2% |
| 78452 | Nuclear medicine study of vessels of heart using drugs or exercise multiple studies | Office | 2021 | 204 | 206 | $301,584 | $73,724 | 24.4% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2021 | 206 | 415 | $151,475 | $37,959 | 25.1% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2021 | 194 | 784 | $126,224 | $37,297 | 29.5% |
| 93017 | Exercise or drug-induced heart and blood vessel stress test with ekg tracing and monitoring | Office | 2021 | 204 | 206 | $24,514 | $4,134 | 16.9% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Office | 2021 | 205 | 207 | $13,869 | $3,579 | 25.8% |
| 93018 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report | Office | 2021 | 205 | 207 | $9,108 | $2,389 | 26.2% |
| 78452 | Nuclear medicine study of vessels of heart using drugs or exercise multiple studies | Office | 2020 | 275 | 280 | $409,920 | $101,881 | 24.9% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2020 | 275 | 558 | $203,670 | $53,883 | 26.5% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2020 | 260 | 1,060 | $170,660 | $49,827 | 29.2% |
| 93017 | Exercise or drug-induced heart and blood vessel stress test with ekg tracing and monitoring | Office | 2020 | 274 | 279 | $33,201 | $5,467 | 16.5% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Office | 2020 | 274 | 279 | $18,693 | $4,961 | 26.5% |
| 93018 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report | Office | 2020 | 274 | 279 | $12,276 | $3,311 | 27.0% |
About Dr. Calvin Lutrin, MD
Dr. Calvin Lutrin, MD is a Nuclear Medicine healthcare provider based in Phoenix, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124086152.
As a Medicare-enrolled provider, Lutrin has provided services to 4,932 Medicare beneficiaries, totaling 8,312 services with total Medicare billing of $618,312. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Nuclear Medicine
- Location Phoenix, AZ
- Active Since 05/01/2006
- Last Updated 03/17/2008
- Taxonomy Code 207U00000X
- Entity Type Individual
- NPI Number 1124086152
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nuclear Medicine Doctors in Phoenix
Dr. Steve Huang, M.d./Ph.d, M.D./PH.D
Nuclear Medicine — Payments: $237.10
Gamal Sidarous, Md, MD
Nuclear Medicine — Payments: $177.55
Mrs. Nancy Youssef, Md, MD
Nuclear Medicine — Payments: $112.74
Michael Lawson, M.d, M.D
Nuclear Medicine — Payments: $20.07
Dr. Frank Schraml, M.d, M.D
Nuclear Medicine
Howard Baxter, Md, MD
Nuclear Medicine